FDA Adverse Event Injury Summary report: N

3F AORTIC BIOPROSTHETIC HEART VALVE

MDR report key: 6520702 · Received April 25, 2017

Report

Report Number
2025587-2017-00670
Event Type
Injury
Date Received
April 25, 2017
Date of Event
April 5, 2017
Report Date
April 9, 2017
Manufacturer
MEDTRONIC 3F THERAPEUTICS, INC.
Product Code
LWR
PMA / PMN Number
P060025
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

TITLE: INITIAL EXPERIENCE WITH AORTIC VALVE REPLACEMENT VIA A MINIMALLY INVASIVE APPROACH: A COMPARISON OF STENTED, STENTLESS AND SUTURELESS VALVES CITATION: MEDICAL SCIENCE MONITOR (2017) 23:1645-1654 (DOI 10.12659/MSM.901780) AUTHORS: KONERTZ, JOHANNA ET AL. EARLIEST DATE OF E-PUBLISH/PUBLISH USED FOR EVENT DATE. NO UNIQUE DEVICE IDENTIFIER (SERIAL/LOT) NUMBERS WERE PROVIDED; WITHOUT THIS INFORMATION IT CANNOT BE DETERMINED WHETHER THIS EVENT HAS BEEN PREVIOUSLY REPORTED. (B)(4).

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFORMATION VIA LITERATURE REVIEW REGARDING THE RESULTS AFTER MINIMALLY INVASIVE STENTED, STENTLESS AND SUTURELESS VALVE. ALL DATA WERE COLLECTED FROM A SINGLE CENTER BETWEEN JANUARY 2010 AND JUNE 2015. THE STUDY POPULATION INCLUDED 79 PATIENTS, 27 OF WHICH WERE IMPLANTED WITH A MEDTRONIC 3F SURGICAL VALVE. THE PATIENTS IMPLANTED WITH THE MEDTRONIC DEVICE WERE PREDOMINANTLY MALE WITH A MEDIAN AGE OF 71.1 YEARS. SERIAL NUMBERS WERE NOT PROVIDED. AMONG ALL PATIENTS IMPLANTED WITH A 3F VALVE, ADVERSE EVENTS INCLUDED: ATRIAL FIBRILLATION (AFIB) TREATED WITH MEDICATION, ELECTROCARDIOGRAM (ECG) CHANGES TREATED WITH A PERMANENT PACEMAKER IMPLANT, INCREASED GRADIENT MEASUREMENTS, MILD REGURGITATION AND BLEEDING TREATED WITH RE-EXPLORATION. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
301909 3F AORTIC BIOPROSTHETIC HEART VALVE HEART-VALVE, NON-ALLOGRAFT TISSUE LWR MEDTRONIC 3F THERAPEUTICS, INC. 1000

Patients

Seq Age Sex Outcome Treatment
1 71 YR Required Intervention